Cathie Wood's ARK Invest Trades

On October 14, 2026, Cathie Wood’s ARK Invest purchased 188,665 shares of CoreWeave - valued at roughly $12.4 million - after the AI cloud infrastructure stock fell 15.5% in a single day to close at $65.78.

CoreWeave shares have tumbled 53% over the past 12 months due to heavy debt worries, holding $52 billion in combined debt and lease obligations as of June 2026 alongside a $640 million second-quarter net interest expense.

Yields on CoreWeave’s $1.25 billion in unsecured bonds due in 2032 recently touched 15%, while the company maintains a revenue backlog exceeding $100 billion.

Simultaneously, ARK sold 31,432 shares of Palantir Technologies for about $6.3 million after that stock climbed more than 60% since early August to end at $200.97.

On October 13, 2026, Cathie Wood's ARK Invest purchased 22,734 Meta Platforms shares for approximately $17.33 million across its ARKW and ARKF exchange-traded funds, reversing previous sales from earlier in October.

ARK also acquired 67,362 Cerebras Systems shares worth nearly $10 million on October 13, 2026, ahead of an October 14 IPO lock-up expiration releasing up to 19.4 million shares.

Meta shares rose 2.6% and Cerebras gained 1.7% on the day of the trades, while Meta stock has climbed roughly 17% over the prior month following the launch of its Muse AI agent models.

In the same trading disclosure, ARK offloaded 901,647 Personalize shares for $14.29 million via its ARKG exchange-traded fund alongside sales of Toast and Everpure shares.

Meta CEO Mark Zuckerberg stated readiness to invest between $100 billion and $200 billion in artificial intelligence infrastructure, including the Prometheus cluster in Ohio and a planned Hyperion site in Louisiana.

On October 8, 2026, Cathie Wood’s ARK Invest sold 29,048 shares of SpaceX worth approximately $4.7 million through its Next Generation Internet ETF, following a prior sale of 54,873 shares on October 6.

ARK also offloaded 22,500 shares of semiconductor maker Advanced Micro Devices valued at nearly $14 million on October 8, contributing to a broader 4% drop in AMD stock driven by concerns over AI spending projections.

To fund these reductions, ARK purchased 159,918 shares of Kratos Defense & Security Solutions for $6.7 million, adding to its position in the defense stock despite the company falling 45% earlier in the year.

SpaceX shares fell over 4% on October 8 following regulatory hurdles for its Starlink satellite internet service in India, shortly before the company announced an agreement to acquire Grain Management’s 800 MHz wireless spectrum portfolio.

In addition to SpaceX and AMD, ARK’s October 8 trading activity included selling 138,032 shares of e-commerce platform Shopify and 202,825 shares of trading platform Robinhood Markets.

Cerebras Systems shares have dropped 58% from their all-time high following a May initial public offering priced at $185, trading around $162 to $170 as of early October 2026.

In the second quarter of 2026, Cerebras posted a core revenue of $210 million—up roughly 74.3% year-over-year—and a narrower-than-expected loss of $0.05 per share compared to analyst forecasts of a $0.17 loss.

OpenAI CEO Sam Altman publicly reaffirmed Cerebras as a close partner on October 5, 2026, helping reverse a temporary sell-off triggered by rumors that OpenAI might bypass Cerebras chips for standard GPUs.

Cerebras utilizes a Wafer-Scale Engine that places computing cores and memory on a single 12-inch silicon wafer, providing a purported 30x advantage in tokens-per-second-per-user over standard graphics processing units.

Cathie Wood's ARK Invest acquired over 117,000 shares for roughly $20 million in early October 2026 as institutional investors absorbed stock ahead of an early November IPO lock-up expiration releasing 30 million shares.

On October 5, 2026, Cathie Wood's ARK Invest sold 90,713 shares of Twist Bioscience valued at $17.1 million across its ARKK and ARKG funds.

ARK acquired 1,482,357 shares of artificial intelligence drug discovery firm Recursion Pharmaceuticals ($RXRX) for $6.1 million on October 5, 2026, as Recursion shares jumped more than 16% on Monday.

The investment firm bought 96,308 shares of gene-editing company Intellia Therapeutics for $1.18 million, adding to a total of over 1,178,000 shares accumulated since September 29 ahead of an FDA decision date scheduled for March 10, 2027.

ARK purchased 115,472 shares of Veracyte for $5.29 million following Phase 3 trial data showing its Decipher Prostate test identifies patients who benefit from adding hormone therapy to radiation.

ARK also reduced its portfolio by selling 27,277 shares of 10x Genomics for $2.55 million and 22,271 shares of CareDx for $1.5 million.

Cerebras shares climbed 6.3% in premarket trading on Monday to $177 per share following a 20% drop last week after reports that OpenAI selected Nvidia graphics processing units instead of Cerebras chips to power the Ultrafast mode for its GPT-6.1 Sol model.

OpenAI Chief Executive Officer Sam Altman posted on X on Friday to calm speculation about a cooling relationship, calling Cerebras a close partner with a deep engagement pushing on the frontiers of speed.

Cerebras completed its initial public offering on the Nasdaq in May 2026, reaching a market value of $95 billion before dropping to just over $39 billion.

Under a multi-year agreement announced in January 2026, Cerebras is contracted to supply OpenAI with 750 megawatts of wafer-scale AI inference capacity valued at over $10 billion through 2028.

On October 1, 2026, Cathie Wood's ARK Invest acquired 233,482 shares of Rocket Lab valued at approximately $16.4 million across three exchange-traded funds.

Concurrently on October 1, ARK offloaded 20,805 shares of Palantir Technologies in a transaction worth roughly $4 million.

Rocket Lab recently secured its largest commercial contract to date, adding 20 launches for Japanese firm Synspective to bring its total missions with the provider to 47.

Rocket Lab reported record second-quarter revenue of $234.1 million—up 62% year-over-year—alongside a record order backlog of nearly $2.36 billion.

Wall Street assigns Rocket Lab a consensus Strong Buy rating with a mean price target of $110.07, representing 56% potential upside from current trading levels.

ARK Invest sold 181,767 shares of Advanced Micro Devices for $110.5 million while simultaneously purchasing 356,681 shares of Nvidia for $81.6 million on September 29, 2026.

Tesla shares rose in after-hours trading after the SEC approved a program allowing retail investors to automatically align their proxy votes with board recommendations.

ARK's Innovation fund added 48,352 Tesla shares valued at $17.28 million, despite the stock falling 1.29% during regular trading hours on Tuesday.

Tesla reported that retail investors voted only 28% of their shares in 2025, significantly trailing the 76.6% participation rate seen among institutional investors.

ARK Invest purchased 359,612 shares of Rocket Lab for $25.1 million across three ETFs, bringing its total position to over 3.2 million shares valued at approximately $225 million.

The firm simultaneously sold 16,422 shares of Alphabet for roughly $5.8 million, reallocating capital from a cash-generating tech giant into a growth-focused space company.

Rocket Lab's long-term growth strategy centers on its Neutron medium-lift reusable rocket, which is currently scheduled for a maiden flight in late 2026, though testing could push the debut into 2027.

ARK also adjusted its biotechnology holdings on Tuesday, acquiring 88,323 shares of Scribe Therapeutics while reducing positions in Twist Bioscience, 10X Genomics, and Everpure.

ARK Invest purchased 51,477 shares of Meta for $38 million on September 21, 2026, the same day the stock surged 11.5% following the successful launch of its Muse AI agent app.

Despite a 5% gain in CrowdStrike shares, ARK sold 28,403 shares of the cybersecurity firm for $7 million, reducing its position in the company.

Muse, Meta's new AI agent, distinguishes itself from standard chatbots by autonomously performing tasks such as booking travel, sending emails, and completing online purchases.

CrowdStrike shares have risen 113% year-to-date, with the company recently introducing new security tools designed to protect AI workloads and identities.

ARK Invest sold approximately $16.4 million in Palantir and AMD shares on September 8, 2026, while simultaneously investing $3.35 million into Archer Aviation.

Despite the sales, Palantir and AMD remain significant holdings for the ARK Innovation ETF, currently ranked as the 11th and 12th largest positions, respectively.

Archer Aviation shares have declined roughly 31% year-to-date, with the company recently announcing a deal to acquire Boeing divisions Insitu, SkyGrid, and Wisk Aero.

The acquisition agreement grants Boeing a 16.5% equity stake in Archer Aviation, which specializes in electric vertical take-off and landing (eVTOL) aircraft.

Ark Invest liquidated approximately $26 million in Palantir Technologies shares and $4.1 million in Advanced Micro Devices stock across its flagship exchange-traded funds on August 31, 2026.

The firm deployed $37.4 million to acquire 456,059 shares of Block and $3.36 million for 35,192 shares of Circle Internet Group, increasing exposure to digital payment and blockchain-linked equities.

Block maintains a corporate treasury of 9,177 Bitcoin valued at approximately $714 million, while Circle has experienced a 52.6% equity appreciation over the trailing 30-day period.

Ark’s portfolio adjustments follow recent earnings reports where Block raised its 2026 profit guidance to $12.5 billion and Palantir exceeded second-quarter revenue expectations with $1.94 billion.

On August 26, 2026, ARK Invest acquired 57,705 shares of Broadcom for $20.5 million while simultaneously liquidating 37,977 shares of Advanced Micro Devices for $18.2 million.

Broadcom is scheduled to report fiscal third-quarter earnings on September 3, with analysts projecting $29.24 billion in revenue, an 83.3% increase over the prior-year period.

The company expects its artificial intelligence semiconductor segment to generate $16 billion in revenue for the quarter, more than double the performance recorded in the same period last year.

ARK Invest also expanded its artificial intelligence-focused portfolio on August 26 by purchasing $12.8 million in Cerebras Systems shares and $13.3 million in Cloudflare shares.

On August 21, 2026, ARK Invest sold 156,110 shares of Palantir for $27.2 million while simultaneously purchasing 205,031 shares of SpaceX for $27.5 million across four exchange-traded funds.

Palantir shares appreciated 43% following its August 3 earnings report, leaving an estimated 10% upside potential, whereas analysts project 66.9% upside for SpaceX.

The SpaceX purchase occurred one day after 319 million shares became eligible for trading in a post-IPO lockup expiration, which briefly pushed the stock below its $135 offering price.

SpaceX has secured over $8 billion in Golden Dome military contracts for satellite systems and launch services, bolstering its defense sector presence.

Circle reported $48 million in net income for Q2 2026, marking a reversal from a prior-year loss, while transaction revenue doubled during the same period.

USDC processed $849 billion in transaction volume during July 2026 and $5.3 trillion in the first half of the year, maintaining a 62% market share.

The Open USD consortium, launched June 30, 2026, introduces new competition for Circle, backed by partners including Stripe, BlackRock, Coinbase, Visa, and Mastercard.

Wall Street analyst price targets for Circle vary significantly, ranging from a low of $37 to a high of $173, reflecting a lack of consensus on the company's valuation model.

ARK Invest holds 3,931,968 shares of Circle, representing 5.14% of its flagship fund, as Cathie Wood argues traditional analysts fail to account for stablecoin disruption.

ARK Invest acquired 101,356 Nvidia shares for approximately $22.8 million on August 17, while simultaneously divesting 25,917 shares of Advanced Micro Devices valued at roughly $13.1 million.

The firm continued its accumulation of Cerebras Systems, purchasing 78,756 shares on August 19 and an additional 35,089 shares on August 18, following a consistent buying pattern since the company's May 2026 IPO.

ARK Invest also expanded its fintech and tokenization exposure by adding 191,671 shares of Block for $15.4 million and 189,796 shares of Securitize for $1.02 million during recent trading sessions.

The portfolio restructuring included liquidating positions in Roblox and Twist Bioscience, alongside a reduction of 22,023 shares in Palantir Technologies valued at approximately $3.8 million.